-
EP2629757
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2629757
| EP2629757 - BRIMONIDINE GEL COMPOSITIONS AND METHODS OF USE [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 26.05.2017 Database last updated on 24.08.2024 | |
| Former | Examination is in progress Status updated on 06.02.2017 | Most recent event Tooltip | 26.05.2017 | Application deemed to be withdrawn | published on 28.06.2017 [2017/26] | Applicant(s) | For all designated states Galderma S.A. Zugerstrasse 8 6330 Cham / CH | [2013/35] | Inventor(s) | 01 /
BUGE, Jean-Christophe 60 Chemin Vallon Barla Le Val D'azur Bat A F-06200 Nice / FR | 02 /
NADAU FOURCADE, Karine Les Restanques de Vaugrenier 1214 Avenue de Vaugrenier F-06270 Villeneuve Loubet / FR | 03 /
MEUNIER, Cyril 1 rue Saint Jacques F-06250 Mougins / FR | [2013/35] | Representative(s) | V.O. P.O. Box 87930 2508 DH Den Haag / NL | [N/P] |
| Former [2013/35] | Jansen, Cornelis Marinus, et al V.O. Johan de Wittlaan 7 2517 JR Den Haag / NL | Application number, filing date | 11805792.6 | 19.10.2011 | WO2011EP68263 | Priority number, date | FR20100058612 | 21.10.2010 Original published format: FR 1058612 | US20100405388P | 21.10.2010 Original published format: US 405388 P | [2013/35] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2012052479 | Date: | 26.04.2012 | Language: | EN | [2012/17] | Type: | A2 Application without search report | No.: | EP2629757 | Date: | 28.08.2013 | Language: | EN | The application published by WIPO in one of the EPO official languages on 26.04.2012 takes the place of the publication of the European patent application. | [2013/35] | Search report(s) | International search report - published on: | EP | 05.07.2012 | Classification | IPC: | A61K9/06, A61K47/32, A61K9/00, A61K31/498 | [2013/35] | CPC: |
A61K31/235 (EP,IL,US);
A61K9/06 (EP,IL,KR,US);
A61K31/498 (EP,IL,KR,US);
A61K45/06 (IL,US);
A61K47/02 (IL,US);
A61K47/10 (IL,US);
A61K47/14 (EP,IL,US);
A61K47/32 (EP,IL,KR,US);
A61K47/34 (IL,US);
A61K8/29 (IL,US);
A61K8/34 (IL,US);
A61K8/345 (IL,US);
A61K8/37 (IL,US);
A61K8/4946 (IL,US);
A61K8/8147 (IL,US);
A61K8/86 (IL,US);
A61K9/0014 (EP,IL,US);
A61P17/00 (EP,IL);
A61P17/04 (EP,IL);
A61P17/06 (EP,IL);
A61P17/10 (EP,IL);
A61P17/16 (EP,IL);
A61Q19/00 (IL,US);
A61Q19/08 (IL,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2013/35] | Extension states | BA | 14.05.2013 | ME | 14.05.2013 | Title | German: | BRIMONIDIN-GELZUSAMMENSETZUNGEN UND VERWENDUNGSVERFAHREN | [2013/35] | English: | BRIMONIDINE GEL COMPOSITIONS AND METHODS OF USE | [2013/35] | French: | COMPOSITIONS DE GEL DE BRIMONIDINE ET LEURS PROCÉDÉS D'UTILISATION | [2013/35] | Entry into regional phase | 14.05.2013 | National basic fee paid | 14.05.2013 | Designation fee(s) paid | 14.05.2013 | Examination fee paid | Examination procedure | 14.05.2013 | Examination requested [2013/35] | 13.12.2013 | Amendment by applicant (claims and/or description) | 01.07.2016 | Despatch of a communication from the examining division (Time limit: M06) | 12.01.2017 | Application deemed to be withdrawn, date of legal effect [2017/26] | 07.02.2017 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2017/26] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 01.07.2016 | Fees paid | Renewal fee | 14.10.2013 | Renewal fee patent year 03 | 14.10.2014 | Renewal fee patent year 04 | 12.10.2015 | Renewal fee patent year 05 | 11.10.2016 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [Y]US2004242588 (DEJOVIN JACK [US], et al) [Y] 1-20 * page 9; examples 6-9 *; | [Y]US2009061020 (THEOBALD KLAUS P [US], et al) [Y] 1-20 * page 1, paragraph 10 * * page 3; example 3 * * page 4; example 5 *; | [Y]WO2009082452 (DEJOVIN JACK A [US]) [Y] 1-20* page 14; example 3 *; | [Y] - GIORDANO F, BETTINI R, DONINI C, GAZZANIGA A, CAIRA MR, ZHANG GG, GRANT DJ., "Physical properties of parabens and their mixtures: solubility in water, thermal behavior, and crystal structures.", J PHARM SCI., (199911), vol. 88, no. 11, pages 1210 - 12196, XP002631268 [Y] 1-20 * the whole document * DOI: http://dx.doi.org/10.1021/JS9900452 | [Y] - GERMAN L. PERLOVICH, SERGEY V. RODIONOV, ANNETTE BAUER-BRANDL, "Thermodynamics of solubility, sublimation and solvation processes of parabens", EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, (20041111), vol. 24, pages 25 - 33, XP002631269 [Y] 1-20 * the whole document * DOI: http://dx.doi.org/10.1016/j.ejps.2004.09.007 | by applicant | US2005020600 | US2006264515 | US2009130027 | - DARBRE ET AL., J. APPL. TOXICOL., (2004), vol. 24, pages 5 - 13 | - BERGE ET AL., J. PHARM. SCI., (1977), vol. 66, pages 1 - 19 | - "Gels and Jellies", OTHER III ET AL., Encyclopedia of Pharmaceutical Technology, MARCEL DEKKER, INC., (2002), vol. 3, pages 1327 - 1344 | - "Gel Dosage Forms: Theory, Formulation, and Processing", PENA ET AL., Topical DrugDelivery Formulations, MARCEL DEKKER, INC., (1990), pages 381 - 388 | - ALFONSO R. GENNARO, Remington: The Science and Practice of Pharmacy, 19th ed.,, (1995), pages 866 - 885 | - ALFONSO R. GENNARO, Remington: The Science andPractice ofPharmacy, 19th ed.,, (1995), pages 1577 - 1591, | US20110603703 | US20110194209 | US20030607439 | US20040763807 | US20040853585 | US20080193098 |